Amazon Great Indian Festival 2020 - Electronics
Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Google
Web www.equitybulls.com
Amazon Great Indian Festival 2020 - Electronics
Stock Report

| More

SRL Diagnostics extends its collaborative endeavors for AI in Histopathology

Posted On: 2020-09-22 20:35:28


Continuing with its transformative efforts in the field of Artificial Intelligence in Pathology, SRL Diagnostics, today announced the second phase of their AI solution development engagement with a technology and data science grant from Microsoft's AI for Health program. While the phase 1 focused on AI models in Cytology and yielded an algorithm for screening of liquid based cytology slides for Cervical Cancer, the second phase will delve into AI models in Histopathology, majorly focusing on Breast, Colorectal and Prostate Cancers. As a part of this engagement, senior Histopathologists from SRL will not only lead and set processes for the AI algorithm development but will also provide research insights required for digitalization of pathology in India.

As per a report by WHO, breast cancer accounts for 2.09 million cases 6,27,000 deaths globally. In India itaccounts for 14% of all cancers in women and is the most common form of cancer.

SRL's efforts in this cutting edge field of Data Science and Artificial Intelligence will help improve the quality and reach of pathology by bringing together Microsoft's Azure and AI technology innovations and SRL's world-class infrastructure and expertise in the study of human cells and tissues.

Commenting on the partnership Anand K., Chief Executive Officer, SRL Diagnostics said, "At SRL, we are committed to pioneering innovation in the field of digital pathology in India. We are delighted to continue to have support from Microsoft's AI for Health program, in developing solutions and generate both social and business value. The AI platform we will build is expected to create a software environment infused with millions of data points and knowledge gained from SRL's expert laboratory professionals. Diagnostics is the first step for any disease management and with the current pandemic scenario the nation and the world at large is facing, the role for diagnostics segment has grown manifold and re-focused the importance of embracing change in the rapidly evolving technology scenario for healthcare. With the growing number of cancer patients, as well as of other diseases, there's a need to quickly and accurately analyze the samples to help doctors arrive at a diagnosis faster."

Commenting on the partnership, John Kahan, Chief Data Analytics Officer and global lead of AI for Health, Microsoft said, "Data is a cornerstone in finding new and innovative ways to tackle some of the world's toughest health challenges. The complexity of diseases requires us to use technology to learn more about how to fight them. We hope that our support will yield helpful insights around diseases such as cancer."

As the largest diagnostic laboratory in the country, SRL Diagnostics has a huge repository of de-identified histopathology slides, which could be of immense value for training an AI algorithm. By increasing efficiency in the initial steps in a biopsy tissue analysis through artificial neural networks, it will be possible for a histopathology laboratory to cut down on inadvertent manual errors and inherent subjectivity, and process more samples in a day with higher level of accuracy.

Microsoft's AI for Health program aims to support organizations to build capabilities of harnessing AI and cloud computing to accelerate innovation in the healthcare industry and improve the lives of people around the world. By working with the healthcare industry's pioneering players, Microsoft has brought its AI capabilities to devices for early and remote detection of diabetic retinopathy to prevent blindness. Microsoft has also recently launched an AI-powered Cardiovascular Disease Risk Score API for Indian population.

Shares of FORTIS HEALTHCARE LTD. was last trading in BSE at Rs.132.5 as compared to the previous close of Rs. 131.25. The total number of shares traded during the day was 19923 in over 526 trades.

The stock hit an intraday high of Rs. 132.8 and intraday low of 129.5. The net turnover during the day was Rs. 2605910.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com

Amazon Great Indian Festival 2020 - Mobiles





Other Headlines:

Cochin Shipyard Ltd signs MoU with Fincantieri

Castrol India Ltd board recommends interim dividend of Rs. 2.50

Hindustan Media Ventures Ltd to invest in ReviewAdda

NACL Industries Limited acquires land in Dahej-II, Bharuch district, Gujarat

Aditya Vision Ltd opens its 53rd showroom at Hajipur, Bihar

Castrol India Ltd Q3CY2020 PAT at Rs. 204.6 crore

Accelya Solutions India Ltd Q1 consolidated net profit at Rs. 2.04 crore

Orient Bell Ltd Q2 consolidated net profit higher at Rs. 3.32 crore

India Ratings & Research assigns Asian Energy IND BBB- / Outlook: Stable) for non-fund based limits

RMC Switchgears Ltd secures order of Rs. 2.02 crore from TPCODL

Airtel to exit the Ghanaian telecom market

Central Bank of India organizes Vigilance Awareness Week

TV18 Broadcast Ltd posts consolidated PAT of Rs. 75.08 crore in Q2FY21

Praxis Home Retail Ltd Q2FY21 loss at Rs. 34.74 crore

Paushak Ltd reports lower Q2FY21 PAT of Rs. 6.11 crore

Network18 Media & Investments Ltd Q2FY21 consolidated loss at Rs. 9.47 crore

ICICI Prudential Life Insurance Company Ltd posts consolidated PAT of Rs. 302.46 crore in Q2FY21

Kriti Nutrients Ltd Q2FY21 PAT at Rs. 1.84 crore

Harley-Davidson & Hero MotoCorp announce agreements for India market

JM Financial Ltd Q2FY21 consolidated net profit climbs to Rs. 139.06 crore

Sanofi India Ltd reports Q3FY20 PAT of Rs. 132.9 crore

Nippon Life India Asset Management Limited Q2FY21 consolidated PAT at Rs. 145.31 crore

K P R Mill Ltd posts higher consolidated PAT of Rs. 112.54 crore in Q2FY21

Kriti Industries India Ltd Q2FY21 consolidated net profit at Rs. 5.51 crore

Bharti Airtel Limited announces Q2FY21 earnings

Micron and Tata Communications Accelerate IoT Deployment With Cloud-Based Virtual SIM

SKF India Ltd posts PAT of Rs. 65.02 crore in Q2FY21

TATA Motors Ltd Q2FY21 consolidated loss at Rs. 314.45 crore

Savita Oil Technologies Ltd Q2FY21 net profit surges to Rs. 37.61 crore

Amara Raja Batteries Ltd Q2FY21 consolidated PAT at Rs. 201.27 crore

JK Agri Genetics Ltd Q2FY21 loss at Rs. 11.01 crore

Man Industries India Ltd Q2FY21 consolidated PAT surges to Rs. 27.28 crore

Gujarat Intrux Ltd Q2FY21 PAT at Rs. 1.21 crore

CEAT Ltd posts consolidated PAT of Rs. 181.86 crore

Suven Life Sciences Ltd Q2 consolidated loss at Rs. 15.65 crore

VST Industries Ltd Q2FY21 net profit rises to Rs. 88.54 crore

Kirloskar Pneumatic Company Ltd posts net profit in Q2FY21

Mangalam Organics Ltd Q2FY21 net profit jumps QoQ basis to Rs. 14.32 crore

Man Industries India Ltd Board declares Interim Dividend of Rs. 2

Equinor Collaborates with TCS to Accelerate its Transformation into a Digital Energy Company

Adani Transmission Ltd board to consider Q2 results on Nov 5, 2020

Vinati Organics Ltd board to announce Q2FY21 results on Nov 5, 2020

Embassy REIT Announces Another Successful Placement of ₹750 Crores Debentures at 6.70% Quarterly Coupon

Ramco Systems signs agreement with NOMAC

GTPL Hathway Ltd acquires additional 10% stake in GTPL Bansidhar Telelink Pvt Ltd

Trident Limited granted a patent for 'Fitted Sheet with Improved Gripping Effect' by United States Patent Office

CSB Bank partners with IIFL Finance for gold loan co-origination

With IPO Smilestone, Happiest Minds contributes a total of 2 million meals to the Akshaya Patra Foundation

CRISIL reaffirms Commercial Paper rating of PNB Gilts Ltd

Steel Strips Wheels Ltd receives export orders of nearly 68,000 wheels







Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2019